A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lu...

by Pavlakou Georgia, Kentepozidis Nikolaos, Syrigos Kostas, Varthalitis Ioannis, Agelidou Athina, Agelaki Sophia, Pallis Athanasios G, Kotsakis Athanasios, Kontopodis Emmanouel, Georgoulias Vassilis
Published 2010-11-01